Periodontal Therapeutic Companies

Dentsply Sirona introduces Perio-Shield™ Plus Gel: This January 2024 launch offers a new topical chlorhexidine gel for plaque control and gum support, potentially expanding treatment options for dentists and patients.

OraPharma Announces FDA Clearance for Evomin, a Novel Gum Disease Treatment: This December 2023 milestone provides a new non-antibiotic, topical option for gingivitis management, potentially impacting market dynamics.

Amyndas Pharmaceuticals reports positive Phase 2b results for AMY-101: This October 2023 study showcases the potential of AMY-101, a novel oral peptide, for treating both gingivitis and periodontitis, sparking further research and development interest.

University of California, San Diego researchers develop microfluidic chip for early periodontitis detection: This January 2024 breakthrough could pave the way for more accurate and rapid diagnosis, leading to earlier intervention and improved treatment outcomes.

• Fibrocell Sciences


• Tolmar Inc


• Eli Lilly & Company


• Align Technology


• Dentsply International


• 3M-ESPE


• Ultradent Products Inc


• Nobel Biocare Holdings AG


• Glidewell Laboratories


• Orapharma


• Kaken Pharmaceutical


• Valeant Pharmaceuticals Int.,